21-Gene Oncotype DX® Recurrence-Score benefits and application in elderly breast cancer patients

被引：0
|
作者：
Chiru, E. D. [1 ]
Kuhar, C. Grasic [2 ]
Oseledchyk, A. [3 ]
Kurzeder, C. [3 ]
Vetter, M. [4 ]
机构：
[1] Cantonal Hosp Baselland, Internal Med, Liestal, Switzerland
[2] Inst Oncol Ljubljana, Oncol, Ljubljana, Slovenia
[3] Univ Hosp Basel, Oncol, Basel, Switzerland
[4] Cantonal Hosp Baselland, Oncol, Liestal, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2022年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11
引用
收藏
页码：43S / 43S
页数：1
相关论文
共 50 条
  • [1] Evaluation Oncotype DX® 21-Gene Recurrence Score and clinicopathological parameters in early stage breast cancer
    Lashen, A. L.
    Toss, M. T.
    Fadhil, W. F.
    Oni, G. O.
    Madhusudan, S. M.
    Rakha, E. R.
    JOURNAL OF PATHOLOGY, 2023, 261 : S10 - S10
  • [2] Use of the 21-gene Oncotype DX® Breast Recurrence Score™ (RS) assay in the neoadjuvant treatment setting
    Robidoux, A.
    McCullough, D.
    Lau, A.
    Stoppler, M.
    Chao, C.
    BREAST, 2017, 32 : S80 - S80
  • [3] The 21-Gene Recurrence Score and Locoregional Recurrence in Breast Cancer Patients
    Jegadeesh, Naresh K.
    Kim, Sunjin
    Prabhu, Roshan S.
    Oprea, Gabriela M.
    Yu, David S.
    Godette, Karen G.
    Zelnak, Amelia B.
    Mister, Donna
    Switchenko, Jeffrey M.
    Torres, Mylin A.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (04) : 1088 - 1094
  • [4] The 21-Gene Recurrence Score and Locoregional Recurrence in Breast Cancer Patients
    Naresh K. Jegadeesh
    Sunjin Kim
    Roshan S. Prabhu
    Gabriela M. Oprea
    David S. Yu
    Karen G. Godette
    Amelia B. Zelnak
    Donna Mister
    Jeffrey M. Switchenko
    Mylin A. Torres
    Annals of Surgical Oncology, 2015, 22 : 1088 - 1094
  • [5] Evaluation oncotype DX® 21-gene recurrence score and clinicopathological parameters: a single institutional experience
    Lashen, Ayat
    Toss, Michael S.
    Fadhil, Wakkas
    Oni, Georgette
    Madhusudan, Srinivasan
    Rakha, Emad
    HISTOPATHOLOGY, 2023, 82 (05) : 755 - 766
  • [6] Evaluating Use Characteristics for the Oncotype Dx 21-Gene Recurrence Score and Concordance With Chemotherapy Use in Early-Stage Breast Cancer
    Chen, Clara
    Dhanda, Rahul
    Tseng, Wan-Yu
    Forsyth, Michael
    Patt, Debra A.
    JOURNAL OF ONCOLOGY PRACTICE, 2013, 9 (04) : 182 - +
  • [7] The 21-Gene Recurrence Score Assay (Oncotype DX™) in Estrogen Receptor-Positive Male Breast Cancer: Experience in an Israeli Cohort
    Grenader, Tal
    Yerushalmi, Rinat
    Tokar, Margarita
    Fried, Georgeta
    Kaufman, Bella
    Peretz, Tamar
    Geffen, David B.
    ONCOLOGY, 2014, 87 (01) : 1 - 6
  • [8] Distribution of the 21-gene recurrence score (RS) assay (Oncotype DX) in carriers of germline mutations associated with breast cancer predisposition syndromes
    Giridhar, Karthik V.
    Choong, Grace M.
    Yadav, Siddartha
    Polley, Eric C.
    Leon-Ferre, Roberto A.
    Liu, Minetta C.
    Goetz, Matthew P.
    Couch, Fergus J.
    CANCER RESEARCH, 2020, 80 (04)
  • [9] Is the 21-gene Breast Cancer Test (Oncotype DX®) Good Value for Money?
    Pronzato, P.
    Plun-Favreau, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S388 - S388
  • [10] Is the 21-Gene Breast Cancer Test (Oncotype DX®) Cost-Effective?
    Pronzato, P.
    Plun-Favreau, J.
    CANCER RESEARCH, 2011, 71
12345